[DISCLOSURE]
Pharma Research Products (214450) announced on May 26 that it has decided to invest 30 billion won (US$26.80 million) and build a second plant in Gangneung, Gangwon Province, to expand its manufacturing facilities.
This amounts to 17.4 percent of its equity capital.
By Hwang You-mee (
theinvestor@heraldcorp.com)